164 related articles for article (PubMed ID: 36741706)
1. A genome-wide association study of germline variation and melanoma prognosis.
Chat V; Dagayev S; Moran U; Snuderl M; Weber J; Ferguson R; Osman I; Kirchhoff T
Front Oncol; 2022; 12():1050741. PubMed ID: 36741706
[TBL] [Abstract][Full Text] [Related]
2. The Expression Quantitative Trait Loci in Immune Pathways and their Effect on Cutaneous Melanoma Prognosis.
Vogelsang M; Martinez CN; Rendleman J; Bapodra A; Malecek K; Romanchuk A; Kazlow E; Shapiro RL; Berman RS; Krogsgaard M; Osman I; Kirchhoff T
Clin Cancer Res; 2016 Jul; 22(13):3268-80. PubMed ID: 26733611
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the folate metabolic pathway genes predict cutaneous melanoma-specific survival.
Dai W; Liu H; Liu Y; Xu X; Qian D; Luo S; Cho E; Zhu D; Amos CI; Fang S; Lee JE; Li X; Nan H; Li C; Wei Q
Br J Dermatol; 2020 Oct; 183(4):719-728. PubMed ID: 31955403
[TBL] [Abstract][Full Text] [Related]
4. Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma.
Zhang W; Liu H; Liu Z; Zhu D; Amos CI; Fang S; Lee JE; Wei Q
Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1101-10. PubMed ID: 25953768
[TBL] [Abstract][Full Text] [Related]
5. Melanoma risk loci as determinants of melanoma recurrence and survival.
Rendleman J; Shang S; Dominianni C; Shields JF; Scanlon P; Adaniel C; Desrichard A; Ma M; Shapiro R; Berman R; Pavlick A; Polsky D; Shao Y; Osman I; Kirchhoff T
J Transl Med; 2013 Nov; 11():279. PubMed ID: 24188633
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2.
Galván-Femenía I; Guindo M; Duran X; Calabuig-Fariñas S; Mercader JM; Ramirez JL; Rosell R; Torrents D; Carreras A; Kohno T; Jantus-Lewintre E; Camps C; Perucho M; Sumoy L; Yokota J; de Cid R
Cancer Treat Res Commun; 2018; 15():21-31. PubMed ID: 30207284
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival.
Yuan H; Liu H; Liu Z; Zhu D; Amos CI; Fang S; Lee JE; Wei Q
Int J Cancer; 2015 Aug; 137(3):638-45. PubMed ID: 25628125
[TBL] [Abstract][Full Text] [Related]
8. Association of genetic variants of
Wang H; Liu H; Dai W; Luo S; Amos CI; Lee JE; Li X; Yue Y; Nan H; Wei Q
Ann Transl Med; 2021 Mar; 9(5):396. PubMed ID: 33842617
[TBL] [Abstract][Full Text] [Related]
9. Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting.
Seviiri M; Scolyer RA; Bishop DT; Newton-Bishop JA; Iles MM; Lo SN; Stretch JR; Saw RPM; Nieweg OE; Shannon KF; Spillane AJ; Gordon SD; Olsen CM; Whiteman DC; Landi MT; Thompson JF; Long GV; MacGregor S; Law MH
J Transl Med; 2022 Sep; 20(1):403. PubMed ID: 36064556
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in TKT and DERA in the nicotinamide adenine dinucleotide phosphate pathway predict melanoma survival.
Gu N; Dai W; Liu H; Ge J; Luo S; Cho E; Amos CI; Lee JE; Li X; Nan H; Yuan H; Wei Q
Eur J Cancer; 2020 Sep; 136():84-94. PubMed ID: 32659474
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer.
Galesloot TE; Grotenhuis AJ; Kolev D; Aben KK; Bryan RT; Catto JWF; Cheng KK; Conroy S; Dyrskjøt L; Fleshner NE; James ND; Lamy P; Lindskrog SV; Malats N; Mengual L; Verhaegh G; Zeegers MP; Kiemeney LALM; Vermeulen SH
Eur Urol Oncol; 2022 Feb; 5(1):70-83. PubMed ID: 34353775
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival.
Dai W; Liu H; Chen K; Xu X; Qian D; Luo S; Amos CI; Lee JE; Li X; Nan H; Li C; Wei Q
Mol Carcinog; 2020 Jun; 59(6):640-650. PubMed ID: 32232919
[TBL] [Abstract][Full Text] [Related]
13. Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma.
Rendleman J; Vogelsang M; Bapodra A; Adaniel C; Silva I; Moogk D; Martinez CN; Fleming N; Shields J; Shapiro R; Berman R; Pavlick A; Polsky D; Shao Y; Osman I; Krogsgaard M; Kirchhoff T
J Med Genet; 2015 Apr; 52(4):231-9. PubMed ID: 25604082
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival.
Xu Y; Wang Y; Liu H; Shi Q; Zhu D; Amos CI; Fang S; Lee JE; Hyslop T; Li X; Han J; Wei Q
Mol Carcinog; 2018 Jan; 57(1):22-31. PubMed ID: 28796414
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival.
Dai W; Liu H; Xu X; Ge J; Luo S; Zhu D; Amos CI; Fang S; Lee JE; Li X; Nan H; Li C; Wei Q
Int J Cancer; 2019 Nov; 145(10):2619-2628. PubMed ID: 30734280
[TBL] [Abstract][Full Text] [Related]
16. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.
Liang L; Mai S; Mai G; Chen Y; Liu L
Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812
[TBL] [Abstract][Full Text] [Related]
17. Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma.
Mao R; Yang F; Zhang T; Li J
Front Immunol; 2021; 12():756282. PubMed ID: 35003069
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma.
Shi Y; Li Z; Zhou Z; Liao S; Wu Z; Li J; Yin J; Wang M; Weng M
PeerJ; 2022; 10():e12646. PubMed ID: 35116193
[TBL] [Abstract][Full Text] [Related]
19. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.
Li B; Wang Y; Xu Y; Liu H; Bloomer W; Zhu D; Amos CI; Fang S; Lee JE; Li X; Han J; Wei Q
Int J Cancer; 2018 Jun; 142(11):2303-2312. PubMed ID: 29313974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
